Montreal Health Innovations Coordinating Center (MHICC), a fast-growing contract research organization, believes LifeSphere’s innovative use of automation and Generative AI is aligned with its pharmacovigilance plans.

Montreal Health Innovations Coordinating Center (MHICC), a fast-growing contract research organization, believes LifeSphere’s innovative use of automation and Generative AI is aligned with its pharmacovigilance plans.

End-to-end functionality helps cut skyrocketing costs of compliance and removes workflow inefficiencies.

The top-tier life sciences company will standardize its Safety operations on the cloud-powered technology platform, LifeSphere, which is propelling life sciences GenAI use cases.

Nuckols will apply decades of both life sciences and technology leadership to enhance innovation and customer focus at ArisGlobal

The international survey reveals that there is currently a pronounced gap between Life Sciences organizations’ intentions and their actual use of next-generation technologies.

LifeSphere Clarity drives efficiencies and reinvents the way Boehringer Ingelheim’s ...

Following a successful inaugural gathering in the USA in February, leading global pharmaceutical organizations & AI specialists will meet in Switzerland on May 15th to further fuel adoption of next-generation technologies transforming Life Sciences R&D.

Launched at Breakthrough 2024, ArisGlobal announced Advanced Intake, Real-World Data Subscription, & its Next-Generation LifeSphere Regulatory Platform LONDON, UK – March 20, 2024 – ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, today announced three cutting-edge product offerings that will transform pharmacovigilance and regulatory operations.